Tobias Holderried
机构: Oberarzt, Universitätsklinik Bonn
每年引用次数
引用次数
引用: 3,243
H-指数: 22
I10-指数 : 27
出版物: 94
Prevalence, therapy and tumour response in patients with rheumatic immune-related adverse events following immune checkpoint inhibitor therapy: a single-centre analysis:
Peter Brossart , Valentin S. Schäfer , Tobias Holderried , Charlotte Behning
Therapeutic Advances in Musculoskeletal Disease 13
2021
Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell Responses
Annkristin Heine , Frank Grünebach , Tobias Holderried , Silke Appel
Molecular Therapy 13 ( 2) 280 -288
22
2006
Conversion from MRD Positive to Negative Status in AML Patients in CR1 after Treatment with an Allogeneic Leukemia-Derived Dendritic Cell Vaccine
Arjan van de Loosdrecht , Janine van Elssen , Bjørn Tore Gjertsen , Eva Maria Wagner
Blood 136 13 -14
2020
Transfection of Dendritic Cells with In Vitro Transcribed RNA Induces Polyclonal CMV-Specific CD8+ and CD4+ Mediated T Cell Responses.
Annkristin Heine , Tobias Holderried , Frank Grünebach , Silke Appel
Blood 104 ( 11) 1354 -1354
2004
Higher number of multidisciplinary tumor board meetings per case leads to improved clinical outcome.
Marius Freytag , Ulrich Herrlinger , Stefan Hauser , Franz G. Bauernfeind
BMC Cancer 20 ( 1) 355
2
2020
713 The PRAME opportunity–high peptide copy numbers, homogenous expression and high prevalence to address a broad patient population across different solid cancers with TCR-based therapeutics
Cedrik Britten , Dejka Araujo , Linus Backert , Carsten Bokemeyer
Journal for ImmunoTherapy of Cancer 10 ( Suppl 2)
2022
P1387: TREATMENT WITH A LEUKEMIA-DERIVED DENDRITIC CELL VACCINE INDUCES INNATE AND ADAPTIVE IMMUNE RESPONSE CORRELATING WITH CLINICAL RESPONSE IN AML PATIENTS IN CR1 WITH MEASURABLE RESIDUAL DISEASE
Hester Van Zeeburg , Satwinder Kaur Singh , Eva Wagner-Drouet , Uwe Platzbecker
HemaSphere 7 ( S3) e95344a6 -e95344a6
1
2023
An Interdisciplinary Outpatient Clinic for Patients with Neurological Sequelae of Cancer Therapies-Results of a Pilot Project at the University Hospital of Bonn
Johannes Weller , Maria Vonnahme , Martin Schumacher , Judith Sirokay
ONCOLOGY RESEARCH AND TREATMENT 43 187 -187
2020
Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy
Mümtaz Köksal , Laura Kersting , Felix Schoroth , Stephan Garbe
Journal of Cancer Research and Clinical Oncology 149 ( 9) 5965 -5973
7
2023
Whole body irradiation with intensity-modulated helical tomotherapy prior to haematopoietic stem cell transplantation: Analysis of organs at risk by dose and its effect on blood kinetics
Mümtaz Köksal , Jonathan Baumert , Danny Jazmati , Felix Schoroth
Journal of Cancer Research and Clinical Oncology 149 ( 10) 7007 -7015
6
2023
Evaluation of factors associated with survival in allogeneic stem cell-transplanted patients admitted to the intensive care unit (ICU)
Michael Serries , Hannah Zenzen , Mario Heine , Tobias Holderried
Hematology 28 ( 1) 2256198 -2256198
2
2023
Optimized Conformal Total Body Irradiation with VMAT Using a Linear-Accelerator-Based Radiosurgery Treatment System in Comparison to the Golden Standard Helical TomoTherapy
Mümtaz Köksal , Oğuzhan Özkan , Tobias Holderried , Annkristin Heine
Cancers 15 ( 17) 4220 -4220
1
2023
P-056 Bispecific Antibodies Improve Outcomes in Patients With Relapsed or Refractory Multiple Myeloma After Car-T Cell Therapy
Maximilan Merz , Danai Dima , Hamza Hashmi , Fabian Mueller
Clinical Lymphoma Myeloma and Leukemia 24 S73 -S74
2024
Refraktäres/rezidiviertes Multiples Myelom: CAR-T-Zell-Therapie zeigt beträchtliche Wirksamkeit
Tobias Holderried
Kompass Onkologie 8 ( 3) 130 -131
2021
FRI0548 PREVALENCE AND THERAPY OF RHEUMATOLOGICAL ADVERSE EVENTS DUE TO IMMUNE CHECKPOINT INHIBITOR THERAPY
P. Brossart , V. S. Schäfer , C. Behning , S. H. Verspohl
Annals of the Rheumatic Diseases 79 875 -876
2020
Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility.
Uta Kunter , Gerda Silling , Gerda Silling , Judith Gecht
European Journal of Haematology
2021
Selective ABO immunoadsorption in hematopoietic stem cell transplantation with major ABO incompatibility.
Uta Kunter , Gerda Silling , Gerda Silling , Judith Gecht
European Journal of Haematology
2021
Human CD8+ Treg after Allogeneic Stem-Cell Transplantation
Tobias A.W. Holderried , Pia Sauerborn , Hye-Jung Kim , Harvey Cantor
Blood 128 ( 22) 2243 -2243
2016
Immunotherapy With RNA Vaccination Coding For TAA In Renal Cell Carcinoma: Update On Immunological Responses and Correlation With Survival
Susanne M Rittig , Maik Häntschel , Katrin J Weimer , Annkristin Heine
Blood 122 ( 21) 1040 -1040
2013
Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells
Güllü Görgün , Tobias A.W. Holderried , David Zahrieh , Donna Neuberg
Journal of Clinical Investigation 115 ( 7) 1797 -1805
344
2005